Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia
Article in Biomedicine & Pharmacotherapy (December 2023)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (December 2023)
Preprint in bioRxiv (August 2023)
Article in Cancer Science (November 2022)